Approaches to improve adherence to pharmacotherapy in patients with schizophrenia

References

• Rummel-KlugeCSchusterTPetersSKisslingWPartial compliance with antipsychotic medication is common in patients with schizophreniaAust N Z J Psychiatry200842538238818473256
   PubMed Web of Science ®Google Scholar
• HudsonTJOwenRRThrushCRA pilot study of barriers to medication adherence in schizophreniaJ Clin Psychiatry200465221121615003075
   PubMed Web of Science ®Google Scholar
• CortesiPAMencacciCLuigiFCompliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA studyBMC Psychiatry2013139823522406
   PubMed Web of Science ®Google Scholar
• DillaTCiudadAAlvarezMSystematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophreniaPatient Prefer Adherence2013727528423589681
   PubMed Web of Science ®Google Scholar
• FarabeeDShenHSanchezSProgram-level predictors of antipsychotic medication adherence among paroleesInt J Offender Ther Comp Criminol200448556157115358931
   PubMed Web of Science ®Google Scholar
• PengXAscher-SvanumHFariesDConleyRRSchuhKJDecline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophreniaClinicoecon Outcomes Res2011391421935327
   PubMedGoogle Scholar
• RabinovitchMBéchard-EvansLSchmitzNJooberRMallaAEarly predictors of nonadherence to antipsychotic therapy in first-episode psychosisCan J Psychiatry2009541283519175977
   PubMed Web of Science ®Google Scholar
• BoardmanGHMcCannTVClarkEAccessing health care professionals about antipsychotic medication related concernsIssues Ment Health Nurs200829773975418592424
   PubMedGoogle Scholar
• LangKMeyersJLKornJRMedication adherence and hospitalization among patients with schizophrenia treated with antipsychoticsPsychiatr Serv201061121239124721123409
   PubMed Web of Science ®Google Scholar
• DiBonaventuraMGabrielSDupclayLGuptaSKimEA patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophreniaBMC Psychiatry2012122022433036
   PubMed Web of Science ®Google Scholar
• KotzèAMvan DelftWFRoosJLContinuity of care of outpatients with schizophrenia in PretoriaS Afr J Psychiatr20101638083
   Web of Science ®Google Scholar
• BondGRDrakeREMueserKTLatimerEAssertive community treatment for people with severe mental illness: critical ingredients and impact on patientsDis Manage Health Outcomes200193141159
   Google Scholar
• MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementBMJ2009339b253519622551
   PubMed Web of Science ®Google Scholar
• SanLBernardoMGómezAMartinezPGonzálezBPeñaMSocio-demographic, clinical and treatment characteristics of relapsing schizophrenic patientsNord J Psychiatry2013671222922429047
   PubMed Web of Science ®Google Scholar
• GilmerTPDolderCRLacroJPAdherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophreniaAm J Psychiatry2004161469269915056516
   PubMed Web of Science ®Google Scholar
• MarcusSCOlfsonMOutpatient antipsychotic treatment and inpatient costs of schizophreniaSchizophr Bull200834117318017578893
   PubMed Web of Science ®Google Scholar
• BeckerMAYoungMSOchshornEDiamondRJThe relationship of antipsychotic medication class and adherence with treatment outcomes and costs for Florida Medicaid beneficiaries with schizophreniaAdm Policy Ment Health200734330731417211716
   PubMed Web of Science ®Google Scholar
• KnappMKingDPugnerKLapuertaPNon-adherence to antipsychotic medication regimens: associations with resource use and costsBr J Psychiatry200418450951615172945
   PubMed Web of Science ®Google Scholar
• GianfrancescoFDRajagopalanKSajatovicMWangRHTreatment adherence among patients with schizophrenia treated with atypical and typical antipsychoticsPsychiatry Res20061442–317718917010448
   PubMed Web of Science ®Google Scholar
• MenzinJBoulangerLFriedmanMMackellJLloydJRTreatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid programPsychiatr Serv200354571972312719504
   PubMed Web of Science ®Google Scholar
• DolderCRLacroJPDunnLBJesteDVAntipsychotic medication adherence: is there a difference between typical and atypical agents?Am J Psychiatry2002159110310811772697
   PubMed Web of Science ®Google Scholar
• VelliganDIWeidenPJSajatovicMThe expert consensus guideline series: adherence problems in patients with serious and persistent mental illnessJ Clin Psychiatry200970Suppl 4146 quiz 47–4819686636
   PubMed Web of Science ®Google Scholar
• WestJCMarcusSCWilkJCountisLMRegierDAOlfsonMUse of depot antipsychotic medications for medication nonadherence in schizophreniaSchizophr Bull2008345995100118093962
   PubMed Web of Science ®Google Scholar
• ZhuBAscher-SvanumHShiLFariesDMontgomeryWMarderSRTime to discontinuation of depot and oral first-generation antipsychotics in the usual care of schizophreniaPsychiatr Serv200859331531718308914
   PubMed Web of Science ®Google Scholar
• OffordSWongBMirskiDBakerRALinJHealthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oralJ Med Econ201316223123923163287
   PubMedGoogle Scholar
• LeuchtCHeresSKaneJMKisslingWDavisJMLeuchtSOral versus depot antipsychotic drugs for schizophrenia – a critical systematic review and meta-analysis of randomised long-term trialsSchizophr Res20111271–3839221257294
   PubMed Web of Science ®Google Scholar
• KirsonNYWeidenPJYermakovSEfficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designsJ Clin Psychiatry201374656857523842008
   PubMed Web of Science ®Google Scholar
• PurvisTLNelsonLAElliottESOutpatient adherence to risperidone long-acting injection following discharge from a state psychiatric hospitalAm J Pharm Benefits201135284290
   Google Scholar
• OlfsonMMarcusSCWilkJWestJCAwareness of illness and nonadherence to antipsychotic medications among persons with schizophreniaPsychiatr Serv200657220521116452697
   PubMed Web of Science ®Google Scholar
• KimEGuptaSBolgeSChenCCWhiteheadRBatesJAAdherence and outcomes associated with copayment burden in schizophrenia: a cross-sectional surveyJ Med Econ201013218519220235753
   PubMedGoogle Scholar
• KozukiYScheppKGAdherence and nonadherence to antipsychotic medicationsIssues Ment Health Nurs200526437939616020055
   PubMedGoogle Scholar
• ZeberJEGrazierKLValensteinMBlowFCLantzPMEffect of a medication copayment increase in veterans with schizophreniaAm J Manag Care2007136 Pt 233534617567234
   PubMed Web of Science ®Google Scholar
• RabinovitchMCassidyCSchmitzNJooberRMallaAThe influence of perceived social support on medication adherence in first-episode psychosisCan J Psychiatry2013581596523327758
   PubMed Web of Science ®Google Scholar
• McCannTVLuSMedication adherence and significant others’ support of consumers with schizophrenia in AustraliaNurs Health Sci200911322823419689630
   PubMed Web of Science ®Google Scholar
• WilkJEWestJCMarcusSCCountisLRegierDAOlfsonMFamily contact and the management of medication non-adherence in schizophreniaCommunity Ment Health J200844537738018465228
   PubMed Web of Science ®Google Scholar
• WeissKASmithTEHullJWPiperACHuppertJDPredictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disordersSchizophr Bull200228234134912693439
   PubMed Web of Science ®Google Scholar
• ValensteinMMcCarthyJFGanoczyDAssertive community treatment in veterans affairs settings: impact on adherence to antipsychotic medicationPsychiatr Serv2013645445451451. e123412131
   PubMed Web of Science ®Google Scholar
• ManuelJICovellNHJacksonCTEssockSMDoes assertive community treatment increase medication adherence for people with co-occurring psychotic and substance use disorders?J Am Psychiatr Nurses Assoc2011171515621659294
   PubMedGoogle Scholar
• PetersenLJeppesenPThorupAA randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illnessBMJ2005331751760216141449
   PubMed Web of Science ®Google Scholar
• AagaardJMüller-NielsenKClinical outcome of assertive community treatment (ACT) in a rural area in Denmark: a case-control study with a 2-year follow-upNord J Psychiatry201165529930521174491
   PubMed Web of Science ®Google Scholar
• KarowAReimerJKönigHHCost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial)J Clin Psychiatry2012733e402e40822490266
   PubMed Web of Science ®Google Scholar
• McHugoGJBeboutRRHarrisMA randomized controlled trial of integrated versus parallel housing services for homeless adults with severe mental illnessSchizophr Bull200430496998215957201
   PubMed Web of Science ®Google Scholar
• GranholmEAnthenelliRMonteiroRSevcikJStolerMBrief integrated outpatient dual-diagnosis treatment reduces psychiatric hospitalizationsAm J Addict200312430631314504023
   PubMed Web of Science ®Google Scholar
• RodrigoCWelgamaSWijeratneTWeligepolaRRajapakseSJayanandaGA prospective cohort study on the role of nonspecialist staff in preventing relapses and improving clinic attendance of patients with schizophreniaIndian J Psychiatry2013551747623439883
   PubMed Web of Science ®Google Scholar
• HudsonTJOwenRRThrushCRArmitageTLThapaPGuideline implementation and patient-tailoring strategies to improve medication adherence for schizophreniaJ Clin Psychiatry2008691748018312040
   PubMed Web of Science ®Google Scholar
• ChenJAscher-SvanumHNyhuisAWReasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and cliniciansPatient Prefer Adherence2011554755422114469
   PubMed Web of Science ®Google Scholar
• DiazENeuseESullivanMCPearsallHRWoodsSWAdherence to conventional and atypical antipsychotics after hospital dischargeJ Clin Psychiatry200465335436015096075
   PubMed Web of Science ®Google Scholar
• McCannTVDeansCClarkELuSA comparative study of antipsychotic medication taking in people with schizophreniaInt J Ment Health Nurs200817642843819128290
   PubMed Web of Science ®Google Scholar
• McCannTVClarkELuSSubjective side effects of antipsychotics and medication adherence in people with schizophreniaJ Adv Nurs200965353454319222651
   PubMed Web of Science ®Google Scholar
• StroupTSMcEvoyJPLiebermanJARevised PORT recommendationsSchizophr Bull200430360961115631251
   PubMed Web of Science ®Google Scholar